Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

All Issuers BankM AG GBC AG First Berlin Equity Research GmbH
26.03.2024 12:36PM
Study issued by First Berlin Equity Research GmbH

M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 13,20 auf EUR 18,00. Zusammenfassung: Wir bekräftigen unsere Kaufempfehlung für die M1 Kliniken AG (M1) und erhöhen unser Ku [ … ]
Read More
Original Research
DE000A0STSQ8 A0STSQ
M1 Kliniken
26.03.2024 10:01AM
Study issued by First Berlin Equity Research GmbH

CR Energy AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu CR Energy AG (ISIN: DE000A2GS625) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 48,00. Zusammenfassung: CR Energy hat vorläufige Kennzahlen für 2023 vorgelegt, die eine weitere gute finanzielle Performance w [ … ]
Read More
Original Research
DE000A2GS625 A2GS62
CR Energy
25.03.2024 10:41AM
Study issued by First Berlin Equity Research GmbH

PSI AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research has published a research update on PSI SE (ISIN: DE000A0Z1JH9). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 30.00 price target. Abstract: PSI has published preliminary key figures for 2023. Sales climbed 8.9% to €269.9m (2022: €247.9m) while EBIT fell to €5.6m (2022: €2 [ … ]
Read More
Original Research
DE000A0Z1JH9 A0Z1JH
PSI Software
26.02.2024 02:06PM
Study issued by First Berlin Equity Research GmbH

Schloss Wachenheim (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research has published a research update on Schloss Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 22.00 price target. Abstract: Although inflation is falling and wage and salary increases are partially compensating for lost consumer purchasing power, the business e [ … ]
Read More
Original Research
DE0007229007 722900
Schloss Wachenheim
09.02.2024 10:26AM
Study issued by First Berlin Equity Research GmbH

ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 3,00 auf EUR 2,80. Zusammenfassung: ad pepper media (APM) hat vorläufige Zahlen für 2023 vorgelegt, d [ … ]
Read More
Original Research
NL0000238145 940883
ad pepper media
20.12.2023 12:07PM
Study issued by First Berlin Equity Research GmbH

M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 11,90 auf EUR 13,20. Zusammenfassung: Im November stärkte M1 seine Botox-Lieferkette durch den Erwerb der Nutri Care GmbH und ihrer hu [ … ]
Read More
Original Research
DE000A0STSQ8 A0STSQ
M1 Kliniken
13.12.2023 10:01AM
Study issued by First Berlin Equity Research GmbH

Haemato AG (von First Berlin Equity Research GmbH): Not Rated

Not Rated
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin hat seine bisherige Buy-Empfehlung und sein bisheriges Kursziel von EUR 34,00 wegen des bevorstehenden Delistings zurückgenommen. Zusammenfassung: Haemato wird die Notierung ihrer Aktien im Open Market der Frank [ … ]
Read More
Original Research
DE000A289VV1 A289VV
Haemato
13.12.2023 09:41AM
Study issued by First Berlin Equity Research GmbH

MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 62,00. Zusammenfassung: Der NAVPS lag zum Neunmonatszeitpunkt bei €50,40 gegenüber €31,90 in 9M/22 (+58%) Die schlep [ … ]
Read More
Original Research
DE000A289V03 A289V0
MPH Health Care
17.11.2023 02:46PM
Study issued by First Berlin Equity Research GmbH

ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 3,00. Zusammenfassung: ad pepper media (APM) hat ihren 9M-Bericht veröffentlicht und die vorl&au [ … ]
Read More
Original Research
NL0000238145 940883
ad pepper media
13.11.2023 12:56PM
Study issued by First Berlin Equity Research GmbH

Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research has published a research update on Schloss Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 22.00 price target. Abstract: Sales rose by 4.7% to €102.7m in Q1 23/24 (FBe: €103.5m; Q1 22/23: €98.0m) as SWA implemented price increases to compensat [ … ]
Read More
Original Research
DE0007229007 722900
Schloss Wachenheim

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2024          
boersengefluester.de · #BGFL · © 2024
The news manufactory
Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Quick Links

About us
Testimonials
Referenzen
Media Kid
Privacy
Terms of use
Imprint

Network

Baha
EQS News
Finanznachrichten
Server 24
Favicon

Partner

BankM
Cometis
Cross Alliance
Fino Digital
GBC
Monetga

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL